This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 36 of the ANK2 protein (p.Leu36Phe). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ANK2 protein function.
ClinVar Genomic variation as it relates to human health
NM_001148.6(ANK2):c.106C>T (p.Leu36Phe)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(1)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
1
criteria provided, single submitter
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001148.6(ANK2):c.106C>T (p.Leu36Phe)
Variation ID: 2738868 Accession: VCV002738868.1
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 4q25 4: 113174437 (GRCh38) [ NCBI UCSC ] 4: 114095593 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 14, 2024 Feb 14, 2024 Jul 8, 2023 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_001148.6:c.106C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001139.3:p.Leu36Phe missense NM_001127493.3:c.43C>T NP_001120965.1:p.Leu15Phe missense NM_001354225.2:c.106C>T NP_001341154.1:p.Leu36Phe missense NM_001354228.2:c.106C>T NP_001341157.1:p.Leu36Phe missense NM_001354230.2:c.151C>T NP_001341159.1:p.Leu51Phe missense NM_001354231.2:c.151C>T NP_001341160.1:p.Leu51Phe missense NM_001354232.2:c.106C>T NP_001341161.1:p.Leu36Phe missense NM_001354235.2:c.106C>T NP_001341164.1:p.Leu36Phe missense NM_001354236.2:c.106C>T NP_001341165.1:p.Leu36Phe missense NM_001354237.2:c.151C>T NP_001341166.1:p.Leu51Phe missense NM_001354239.2:c.43C>T NP_001341168.1:p.Leu15Phe missense NM_001354240.2:c.151C>T NP_001341169.1:p.Leu51Phe missense NM_001354241.2:c.151C>T NP_001341170.1:p.Leu51Phe missense NM_001354242.2:c.151C>T NP_001341171.1:p.Leu51Phe missense NM_001354243.2:c.43C>T NP_001341172.1:p.Leu15Phe missense NM_001354244.2:c.43C>T NP_001341173.1:p.Leu15Phe missense NM_001354245.2:c.106C>T NP_001341174.1:p.Leu36Phe missense NM_001354246.2:c.106C>T NP_001341175.1:p.Leu36Phe missense NM_001354249.2:c.43C>T NP_001341178.1:p.Leu15Phe missense NM_001354252.2:c.43C>T NP_001341181.1:p.Leu15Phe missense NM_001354253.2:c.43C>T NP_001341182.1:p.Leu15Phe missense NM_001354254.2:c.43C>T NP_001341183.1:p.Leu15Phe missense NM_001354255.2:c.43C>T NP_001341184.1:p.Leu15Phe missense NM_001354256.2:c.43C>T NP_001341185.1:p.Leu15Phe missense NM_001354257.2:c.43C>T NP_001341186.1:p.Leu15Phe missense NM_001354258.2:c.106C>T NP_001341187.1:p.Leu36Phe missense NM_001354260.2:c.43C>T NP_001341189.1:p.Leu15Phe missense NM_001354261.2:c.88C>T NP_001341190.1:p.Leu30Phe missense NM_001354262.2:c.43C>T NP_001341191.1:p.Leu15Phe missense NM_001354264.2:c.43C>T NP_001341193.1:p.Leu15Phe missense NM_001354265.2:c.106C>T NP_001341194.1:p.Leu36Phe missense NM_001354266.2:c.43C>T NP_001341195.1:p.Leu15Phe missense NM_001354267.2:c.43C>T NP_001341196.1:p.Leu15Phe missense NM_001354268.2:c.106C>T NP_001341197.1:p.Leu36Phe missense NM_001354269.3:c.94C>T NP_001341198.1:p.Leu32Phe missense NM_001354270.2:c.43C>T NP_001341199.1:p.Leu15Phe missense NM_001354271.2:c.43C>T NP_001341200.1:p.Leu15Phe missense NM_001354272.2:c.43C>T NP_001341201.1:p.Leu15Phe missense NM_001354273.2:c.106C>T NP_001341202.1:p.Leu36Phe missense NM_001354274.2:c.43C>T NP_001341203.1:p.Leu15Phe missense NM_001354275.2:c.43C>T NP_001341204.1:p.Leu15Phe missense NM_001354276.2:c.43C>T NP_001341205.1:p.Leu15Phe missense NM_001354277.2:c.43C>T NP_001341206.1:p.Leu15Phe missense NM_001386142.1:c.43C>T NP_001373071.1:p.Leu15Phe missense NM_001386143.1:c.43C>T NP_001373072.1:p.Leu15Phe missense NM_001386144.1:c.151C>T NP_001373073.1:p.Leu51Phe missense NM_001386146.1:c.43C>T NP_001373075.1:p.Leu15Phe missense NM_001386147.1:c.88C>T NP_001373076.1:p.Leu30Phe missense NM_001386148.2:c.94C>T NP_001373077.1:p.Leu32Phe missense NM_001386149.1:c.43C>T NP_001373078.1:p.Leu15Phe missense NM_001386150.1:c.43C>T NP_001373079.1:p.Leu15Phe missense NM_001386151.1:c.43C>T NP_001373080.1:p.Leu15Phe missense NM_001386152.1:c.151C>T NP_001373081.1:p.Leu51Phe missense NM_001386153.1:c.43C>T NP_001373082.1:p.Leu15Phe missense NM_001386154.1:c.43C>T NP_001373083.1:p.Leu15Phe missense NM_001386156.1:c.43C>T NP_001373085.1:p.Leu15Phe missense NM_001386157.1:c.43C>T NP_001373086.1:p.Leu15Phe missense NM_001386158.1:c.43C>T NP_001373087.1:p.Leu15Phe missense NM_001386160.1:c.88C>T NP_001373089.1:p.Leu30Phe missense NM_001386161.1:c.43C>T NP_001373090.1:p.Leu15Phe missense NM_001386162.1:c.43C>T NP_001373091.1:p.Leu15Phe missense NM_001386174.1:c.157C>T NP_001373103.1:p.Leu53Phe missense NM_001386175.1:c.157C>T NP_001373104.1:p.Leu53Phe missense NM_001386186.2:c.94C>T NP_001373115.1:p.Leu32Phe missense NM_001386187.2:c.94C>T NP_001373116.1:p.Leu32Phe missense NM_020977.5:c.106C>T NP_066187.2:p.Leu36Phe missense NC_000004.12:g.113174437C>T NC_000004.11:g.114095593C>T NG_009006.2:g.361355C>T LRG_327:g.361355C>T LRG_327t1:c.106C>T LRG_327p1:p.Leu36Phe LRG_327t2:c.43C>T LRG_327p2:p.Leu15Phe - Protein change
- L36F, L32F, L15F, L30F, L51F, L53F
- Other names
- -
- Canonical SPDI
- NC_000004.12:113174436:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| ANK2 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
2665 | 3251 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
Jul 8, 2023 | RCV003531596.2 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(Jul 08, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Long QT syndrome
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004300990.1
First in ClinVar: Feb 14, 2024 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 36 of the ANK2 protein (p.Leu36Phe). … (more)
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 36 of the ANK2 protein (p.Leu36Phe). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ANK2 protein function. (less)
|
Comment:
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 36 of the ANK2 protein (p.Leu36Phe). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ANK2 protein function.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.